3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckman, RA; McFall, PJ; Sikic, BI; Smith, SD | 1 |
| Acton, EM; Andersson, BS; Bakic, M; Mullins, TD; Newman, RA; Silberman, LE; Wassermann, K; Zwelling, LA | 1 |
2 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Leukemia
| Article | Year |
|---|---|
Doxorubicin and the alkylating anthracycline 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin: comparative in vitro potency against leukemia and bone marrow cells.
Topics: Antibiotics, Antineoplastic; Bone Marrow; Doxorubicin; Drug Resistance; Hematopoietic Stem Cells; Humans; Leukemia; Tumor Cells, Cultured | 1988 |
Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.
Topics: Antibiotics, Antineoplastic; Cell Nucleolus; Cell Survival; Cells, Cultured; Dactinomycin; DNA, Neoplasm; Doxorubicin; Humans; Leukemia; RNA, Neoplasm; Structure-Activity Relationship | 1986 |